Amphibian road mortality in Europe: a meta-analysis with new data from Poland

While the increasing vehicular traffic is widely suspected to play a role in the worldwide amphibian population decline, the research of amphibian road mortality is scarce, fragmented, fraught with methodological problems, and largely inconclusive. As the first attempt at a synthesis, we analyzed all available data on amphibian mortality in Europe and combined them with four previously unpublished surveys conducted by us. Based on our recalculation of road-kill counts in terms of species-specific road-kill recordability, we conclude that, in lowland Central Europe, the common toads, Bufo bufo, are the most common victims of vehicular traffic in suburban landscapes, while the common frogs, Rana temporaria and Triturus newts, prevail in rural landscapes. The green frogs also tend to be more frequent in rural areas. Common tree frogs, Hyla arborea, are unexpectedly rare in the road-kill record despite their terrestrial and migratory habits. In consideration of problems with obtaining accurate amphibian population estimates, we further propose the road kills-to-spawners ratio (R/S) as a working measure of the impact of road mortality on a local population. While the R/S ratio may not reflect the losses to an entire local amphibian population, it is free of the errors of whole-population estimates, which are notoriously difficult for amphibians. When corrected for species-specific road-kill recordability, most results suggest that the impact of roads on newts may have been underestimated and that the impact on common frog populations may be higher than on those of common toads. Electronic supplementary material  The online version of this article (doi:) contains supplementary material, which is available to authorized users. Communicated by H. Kierdorf     

D-amino Acid Oxidase as an Industrial Biocatalyst

Biocatalysis driven by D-amino acid oxidase is a significant example of the commercial production of high value-added intermediates using enzyme-based technology. The results of the most recent research on this FAD-dependent catalyst are reported here. In particular, insight is given of how in the past few years the main industrial application of this enzyme, i.e. the stereospecific bioconversion of cephalosporin C to glutaryl-7-amino cephalosporanic acid in the two-step production of 7-amino cephalosporanic acid, has been implemented by improving its production and by engineering of the biocatalyst. The set-up and the optimization of different conditions for carrying out the process under different procedures have also been updated.     

Circadian Profile of Serum Melatonin in Cushing's Disease and Acromegaly

We evaluated the circadian profiles of serum melatonin (MT) and Cortisol in 6 patients with Cushing's disease while those of serum MT and GH were evaluated in 8 patients with acromegaly. The control group consisted of 15 healthy subjects in whom MT, Cortisol and GH were determined. The presence of a circadian rhythmicity was validated by the cosinor method, while the diurnal and nocturnal amount of MT secretion were expressed in terms of area under the curve. Gross alterations of MT rhythm were not apparent in Cushing's patients. In acromegalics, we observed a blunted day-night oscillation of MT accounted for by a significant increase of its secretion during the day-time period.     

Overexpression of a recombinant wild-type and His-tagged Bacillus subtilis glycine oxidase in Escherichia coli.

We have cloned the gene coding for the Bacillus subtilis glycine oxidase (GO), a new flavoprotein that oxidizes glycine and sarcosine to the corresponding alpha-keto acid, ammonia and hydrogen peroxide. By inserting the DNA encoding for GO into the multiple cloning site of the expression vector pT7.7 we produced a recombinant plasmid (pT7-GO). The pT7-GO encodes a fully active fusion protein with six additional residues at the N-terminus of GO (MARIRA). In BL21(DE3)pLysS Escherichia coli cells, and under optimal isopropyl thio-beta-D-galactoside induction conditions, soluble and active chimeric GO was expressed up to 1.14 U g(-1) of cell (and a fermentation yield of 3.82 U x L(-1) of fermentation broth). An N-terminal His-tagged protein (HisGO) was also successfully expressed in E. coli as a soluble protein and a fully active holoenzyme. HisGO represents approximately 3.9% of the total soluble protein content of the cell. The His-tagged GO was purified in a single step by nickel-chelate chromatography to a specific activity of 1.06 U x mg(-1) protein at 25 degrees C and with a yield of 98%. The characterization of the purified enzyme showed that GO is a homotetramer of approximately 180 kDa with the spectral properties typical of flavoproteins. GO exhibits good thermal stability, with a Tm of 46 degrees C after 30 min incubation; its stability is maximal in the 7.0-8.5 pH range. A comparison of amino-acid sequence and substrate specificity indicates that GO has similarities to other flavoenzymes acting on primary amines and on D-amino acids.     

D-amino Acid Oxidase as an Industrial Biocatalyst

Biocatalysis driven by D-amino acid oxidase is a significant example of the commercial production of high value-added intermediates using enzyme-based technology. The results of the most recent research on this FAD-dependent catalyst are reported here. In particular, insight is given of how in the past few years the main industrial application of this enzyme, i.e. the stereospecific bioconversion of cephalosporin C to glutaryl-7-amino cephalosporanic acid in the two-step production of 7-amino cephalosporanic acid, has been implemented by improving its production and by engineering of the biocatalyst. The set-up and the optimization of different conditions for carrying out the process under different procedures have also been updated.     

A process for bioconversion of cephalosporin C by Rhodotorula gracilis D-amino acid oxidase

Summary A process for the production (in a stirred tank reactor) of glutaryl-7-ACA from cephalosporin C using immobilized D-amino acid oxidase is described. Results so obtained under optimal conditions (1.2 mg coupled enzyme/L, pH 8.5, 2 mM cephalosporin C) point to a system which shows high conversion efficiency and a remarkable operational stability. No exogenous H₂O₂ is requested to shift the reaction equilibrium toward glutaryl-7-ACA production, nor any side product is detected. The immobilized system productivity was 54 g/day/mg of enzyme. This process represents the first reported case of a reactor successfully developed with a DAAO for bioconversion of cephalosporin C.